Clinical Trial Update: BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating BBR 3464 for locally advanced or metastatic pancreatic cancer that cannot be treated with surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BBR 3464

Snippet

Sponsor: Theradex | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN